Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events? Commentary

Andre M Dewolf, Michael Messod Abecassis*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)422-423
Number of pages2
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume4
Issue number8
DOIs
StatePublished - Aug 1 2007

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this